Trial intelligence / Profile preview

Fisetin for knee osteoarthritis

NCT04210986Phase 2Completed

Sponsor
Steadman Philippon Research Institute
Start
Jan 2020
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fisetin in osteoarthritis (OA), sponsored by Steadman Philippon Research Institute. Started Jan 2020; status: completed.

02

Drugs

fisetin
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04210986.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04210986.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call